| | Title | Authors / Editors | Date |
|
unige:161397 |
The global approach to rehabilitation following an osteoporotic fragility fracture: A review of the rehabilitation working group of the International Osteoporosis Foundation (IOF) committee of scientific advisors |
Pinto, D.; Alshahrani, M.; Chapurlat, R.; Chevalley, Thierry; ... Bruyere, O. |
2022 |
|
unige:143947 |
Assessment of cardiovascular safety of anti-osteoporosis drugs |
Fuggle, N. R.; Cooper, C.; Harvey, N. C.; Al-Daghri, N.; ... Reginster, J. Y. |
2020 |
|
unige:33715 |
What is the predictive value of MRI for the occurrence of knee replacement surgery in knee osteoarthritis? |
Pelletier, J.-P.; Cooper, C.; Peterfy, C.; Reginster, J.-Y.; ... Guermazi, A. |
2013 |
|
unige:33720 |
Value of biomarkers in osteoarthritis: current status and perspectives |
Lotz, M.; Martel-Pelletier, J.; Christiansen, C.; Brandi, M.-L.; ... Reginster, J.-Y. |
2013 |
|
unige:20810 |
Relationship between 3-month changes in biochemical markers of bone remodelling and changes in bone mineral density and fracture incidence in patients treated with strontium ranelate for 3 years |
Bruyere, O.; Collette, J.; Rizzoli, René; Decock, C.; ... Reginster, J-Y |
2010 |
|
unige:20811 |
The need for a transparent, ethical, and successful relationship between academic scientists and the pharmaceutical industry: a view of the Group for the Respect of Ethics and Excellence in Science (GREES) |
Bruyere, O.; Kanis, J. A.; Ibar-Abadie, M-E; Alsayed, N.; ... Reginster, J-Y |
2010 |
|
unige:20063 |
Management of osteoporosis in the elderly |
Rizzoli, René; Bruyere, O.; Cannata-Andia, J. B.; Devogelaer, J -P; ... Reginster, J -Y |
2009 |
|
unige:19079 |
Post-fracture management of patients with hip fracture: a perspective |
Bruyere, O.; Brandi, M-L; Burlet, N.; Harvey, N.; ... Akesson, K. |
2008 |
Bruyere, O.
add all
remove all
